HRT Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,380
| Closed | -$216K | – | 3039 |
|
|
2025
Q1 | $216K | Sell |
2,380
-3,198
| -57% | -$290K | ﹤0.01% | 1748 |
|
|
2024
Q4 | $481K | Buy |
+5,578
| New | +$481K | ﹤0.01% | 1279 |
|
|
2024
Q3 | – | Sell |
-8,031
| Closed | -$734K | – | 2771 |
|
|
2024
Q2 | $734K | Buy |
+8,031
| New | +$734K | ﹤0.01% | 1051 |
|
|
2024
Q1 | – | Sell |
-46,430
| Closed | -$3.78M | – | 2746 |
|
|
2023
Q4 | $3.78M | Buy |
46,430
+18,884
| +69% | +$1.54M | 0.03% | 381 |
|
|
2023
Q3 | $2.2M | Buy |
+27,546
| New | +$2.2M | 0.02% | 531 |
|
|
2023
Q2 | – | Sell |
-67,098
| Closed | -$5.21M | – | 2884 |
|
|
2023
Q1 | $5.21M | Buy |
67,098
+62,036
| +1,226% | +$4.82M | 0.06% | 244 |
|
|
2022
Q4 | $393K | Sell |
5,062
-40,941
| -89% | -$3.18M | 0.01% | 1448 |
|
|
2022
Q3 | $3.09M | Buy |
46,003
+2,952
| +7% | +$198K | 0.03% | 440 |
|
|
2022
Q2 | $3.31M | Buy |
+43,051
| New | +$3.31M | 0.04% | 370 |
|